Sinopharm Group Financials
| X2S Stock | EUR 2.57 0.01 0.39% |
Sinopharm |
Understanding current and past Sinopharm Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sinopharm Group's financial statements are interrelated, with each one affecting the others. For example, an increase in Sinopharm Group's assets may result in an increase in income on the income statement.
Please note, the presentation of Sinopharm Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sinopharm Group's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sinopharm Group's management manipulating its earnings.
Sinopharm Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sinopharm Group's current stock value. Our valuation model uses many indicators to compare Sinopharm Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sinopharm Group competition to find correlations between indicators driving Sinopharm Group's intrinsic value. More Info.Sinopharm Group Co is rated first in current valuation category among its peers. It is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for Sinopharm Group Co is about 17,937,579,674 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sinopharm Group's earnings, one of the primary drivers of an investment's value.Sinopharm Group Systematic Risk
Sinopharm Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sinopharm Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Sinopharm Group correlated with the market. If Beta is less than 0 Sinopharm Group generally moves in the opposite direction as compared to the market. If Sinopharm Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sinopharm Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sinopharm Group is generally in the same direction as the market. If Beta > 1 Sinopharm Group moves generally in the same direction as, but more than the movement of the benchmark.
Sinopharm Group January 7, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sinopharm Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sinopharm Group Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sinopharm Group Co based on widely used predictive technical indicators. In general, we focus on analyzing Sinopharm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sinopharm Group's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.17 | |||
| Information Ratio | 0.0541 | |||
| Maximum Drawdown | 7.75 | |||
| Value At Risk | (3.20) | |||
| Potential Upside | 2.89 |
Complementary Tools for Sinopharm Stock analysis
When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |